Marina Chiara Garassino to Survivors
This is a "connection" page, showing publications Marina Chiara Garassino has written about Survivors.
Connection Strength
0.050
-
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide. Lung Cancer. 2023 12; 186:107418.
Score: 0.050